G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old
- PMID: 26732817
- PMCID: PMC5005865
- DOI: 10.1007/s11357-015-9869-7
G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old
Abstract
This study aimed to examine the possible association between G-395A polymorphism in the promoter region of the KLOTHO gene and cognitive impairment among Chinese nonagenarians and centenarians. This study is a secondary analysis of the Project of Longevity and Aging in Dujiangyan (PLAD) study. Community-dwelling Chinese people aged 90 years or older were included. G-395A (rs1207568) genotyping in the promoter region of the KLOTHO gene was performed using the TaqMan allelic discrimination assay. Cognitive function was assessed with the mini-mental status examination (MMSE). A total of 706 participants (68.0 % female; mean age 93.5 ± 3.6 years) were included. The KLOTHO G-395A polymorphism genotype frequencies for the whole sample were 2.0 % AA, 30.3 % GA, and 67.7 % GG. The GG genotype frequencies for the cognitive impairment and control groups were 70.2 and 62.7 %, respectively. Cognitive impairment prevalence was significantly lower in the GA+AA group than in the GG genotype group (61.4 vs. 69.0 %, p = 0.044). GA+AA genotype subjects had a significantly lower risk of cognitive impairment (odds ratio 0.66; 95 % confidence interval 0.44 to 0.98) than GG genotype individuals after adjusting for age, gender, and other relevant risk factors. KLOTHO G-395A polymorphism associates with reduced cognitive impairment in a sample of Chinese nonagenarians and centenarians.
Keywords: Cognitive impairment; KLOTHO gene; Single nucleotide polymorphism.
Conflict of interest statement
Compliance with ethical standards Written informed consent was obtained from all subjects or their legal proxies. The Research Ethics Committee of Sichuan University approved the study protocol. Conflict of interests The authors declare that they have no competing interests. Funding sources This work was supported by the Project of Science and technology Bureau of Sichuan Province (2006Z09-006-4) and the Health Care Committee of Sichuan Province Health Department (2012-GANJIANBAN-7). The sponsor had no role in the design, methods, data collection, analysis, and preparation of this paper.
Similar articles
-
G-395A polymorphism in the promoter region of the KLOTHO gene associates with frailty among the oldest-old.Sci Rep. 2018 Apr 30;8(1):6735. doi: 10.1038/s41598-018-25040-4. Sci Rep. 2018. PMID: 29712948 Free PMC article.
-
G-395A polymorphism in the promoter region of the KLOTHO gene and hypertension among elderly (90 years and older) Chinese individuals.Genet Mol Res. 2015 Dec 1;14(4):15444-52. doi: 10.4238/2015.November.30.22. Genet Mol Res. 2015. PMID: 26634510
-
The Klotho gene G-395A polymorphism and metabolic syndrome in very elderly people.BMC Geriatr. 2016 Feb 15;16:46. doi: 10.1186/s12877-016-0221-6. BMC Geriatr. 2016. PMID: 26880028 Free PMC article.
-
A potential regulatory single nucleotide polymorphism in the promoter of the Klotho gene may be associated with essential hypertension in the Chinese Han population.Clin Chim Acta. 2010 Mar;411(5-6):386-90. doi: 10.1016/j.cca.2009.12.004. Epub 2009 Dec 11. Clin Chim Acta. 2010. PMID: 20005218
-
Polymorphism of klotho G-395A and susceptibility of coronary artery disease in East-Asia population: a meta-analysis.Int J Clin Exp Med. 2015 Feb 15;8(2):1582-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932086 Free PMC article. Review.
Cited by
-
Role of Klotho Protein in Neuropsychiatric Disorders: A Narrative Review.Indian J Clin Biochem. 2023 Jan;38(1):13-21. doi: 10.1007/s12291-022-01078-0. Epub 2022 Aug 13. Indian J Clin Biochem. 2023. PMID: 36684492 Free PMC article. Review.
-
Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders.Front Psychiatry. 2021 Oct 13;12:682691. doi: 10.3389/fpsyt.2021.682691. eCollection 2021. Front Psychiatry. 2021. PMID: 34721095 Free PMC article.
-
Exploiting the neuroprotective effects of α-klotho to tackle ageing- and neurodegeneration-related cognitive dysfunction.Neuronal Signal. 2021 Jun 14;5(2):NS20200101. doi: 10.1042/NS20200101. eCollection 2021 Jun. Neuronal Signal. 2021. PMID: 34194816 Free PMC article. Review.
-
Klotho and the Treatment of Human Malignancies.Cancers (Basel). 2020 Jun 23;12(6):1665. doi: 10.3390/cancers12061665. Cancers (Basel). 2020. PMID: 32585905 Free PMC article. Review.
-
Klotho and vitamin D in multiple sclerosis: an Italian study.Arch Med Sci. 2019 Aug 2;16(4):842-847. doi: 10.5114/aoms.2019.86969. eCollection 2020. Arch Med Sci. 2019. PMID: 32542086 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources